Injury Incidence, Severity and Burden in Elite Youth Rugby Players (RUBYS)

Injury Incidence, Severity and Burden Over Two Consecutive Seasons in French Elite Youth Rugby Players of Rugby Club Toulonnais

Observational cohort study, with a closed, both retrospective and prospective design, aiming to describe the incidence, severity, and burden of injuries among male and female players enrolled in the Rugby Club Toulonnais (RCT) Association program (U14 to U18 categories) over two consecutive seasons (2024-2025 and 2025-2026), based on routinely collected medical data recorded in the Askamon software.

Youth male and female players registered with the RCT Association program, starting from the U14 category, and enrolled in partner school structures within the Toulon Metropolitan area. These players benefit from an integrated academic and athletic support program.

Inclusion criteria: male or female players licensed with the RCT Association from the U14 category and above; under the medical supervision of the RCT Association; having sustained at least one injury requiring a medical consultation between August 1, 2024, and June 30, 2026; non-opposition from the participant and/or their legal guardians after being informed about the study.

Exclusion criteria: opposition from the participant or their parents/legal guardians to the use of personal data for research purposes; players not under the medical responsibility of the RCT Association.

Enrollment (estimated): approximately 200 licensed players per season, with an estimated 400 injuries per season, and exhaustive inclusion of all injured players from the active registry over two seasons.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The RUBYS study is an observational closed cohort conducted over two consecutive competitive seasons (2024-2025 and 2025-2026) in youth rugby players from the RCT (Rugby Club Toulonnais) Association. It focuses on the epidemiology of rugby-related injuries in adolescents enrolled in a structured dual project (school and sport) in the Toulon metropolitan area.

Young players (boys and girls) aged approximately 13 to 18 years, licensed in the RCT Association from the U14 category upwards, benefit from adapted school timetables and regular supervised training sessions. These athletes are monitored medically by the Sports Medicine and Traumatology Unit (UMTS) of the Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer (CHITS), under the responsibility of the principal investigator. All injuries requiring medical consultation are routinely recorded in the Askamon software, which centralizes clinical information, exposure data and follow-up for each player.

The study does not modify usual care and does not introduce any additional medical procedures beyond those required for standard injury management. When an injury occurs, the player is assessed and treated according to usual practice (club doctor, attending physician or emergency services, with referral to specialists and use of imaging or surgery if needed). Information regarding the type of injury, anatomical location, circumstances, and days lost from rugby is recorded as part of routine clinical documentation and sports records (match sheets, training attendance registers), then entered into Askamon. No specific intervention, randomization or additional biological sampling is planned within the framework of this protocol.

For the purposes of the study, a pseudonymized extraction of Askamon will be performed and will include all players with at least one injury requiring medical consultation between August 1, 2024, and June 30, 2026. Each injury event will be considered as an observation, and multiple injuries in the same player will be analysed separately. The dataset will include demographic variables (age, sex), relevant medical history where available, detailed injury characteristics (diagnosis, lesion type, involved body region) and severity expressed as time-loss days until full return to competition. Injuries will be categorized according to international rugby consensus definitions (World Rugby/International Rugby Board [IRB]) to ensure comparability with existing literature.

Non-medical variables related to rugby participation will also be extracted: playing position (forwards or backs), competition category, context of occurrence (match versus training), match situation or training drill, recurrence, playing surface (natural or synthetic), type of competition, venue, period of the season, environmental conditions (temperature, weather), equipment (footwear condition) and perceived fatigue where available. These contextual factors will be used to explore potential modifiable risk factors and high-risk situations. The exposure denominator (player-hours) will be estimated from training and match schedules, attendance records and competition data provided by the RCT Association.

The primary analysis will consist of calculating injury incidence rates expressed as the number of injuries per 1000 player-hours of exposure, overall and stratified by sex, age category, playing position and context (training versus match). Secondary analyses will describe the distribution of injuries by type, anatomical site and severity categories, and will assess the relative contribution of different mechanisms and contexts to overall injury burden. Time-loss injuries will be classified into predefined severity grades based on the number of days of absence from full rugby participation, allowing the identification of injuries with the highest impact on players and on team performance.

From a methodological standpoint, the study is primarily descriptive, aiming at providing precise estimates of incidence and severity in the entire eligible population, rather than testing a specific intervention. All eligible players will be included, so no formal a priori sample size calculation is required. The precision of incidence estimates (95% confidence intervals) will be evaluated post hoc according to the actual number of injuries and exposure hours collected. Where appropriate, multivariable models may be used to explore associations between injury occurrence and potential risk factors (e.g. position, age category, match versus training, playing surface), while acknowledging the observational nature of the data and the limitations regarding causal inference.

Participants and their legal guardians will be informed through a written information letter describing the objectives of the research, the nature of the data used, the pseudonymization process and their rights (access, rectification, opposition and withdrawal). Non-opposition from parents or legal guardians is required for inclusion. In case of withdrawal, all data relating to the concerned player will be definitively deleted from the research dataset. No additional burden or constraint is imposed on players, families or staff.

Data will be pseudonymized before analysis, with the identification key kept securely at the Sports Medicine and Traumatology Unit (UMTS) of the CHITS and not available to the statisticians. The dataset will be stored on secure institutional servers, in compliance with applicable regulations on personal data protection. Data will be retained for a limited period (up to 2 years after the last publication, or 3 years after the end of data collection in the absence of publication), then archived for 15 years according to national regulations on clinical research archiving. Results will be disseminated through scientific publications and presentations, with the aim of informing prevention strategies, improving rehabilitation pathways and contributing to safer rugby practice in youth populations.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Var
      • Toulon, Var, France, 83100
      • Toulon, Var, France, 83200
        • Recruiting
        • RCT Association
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Youth rugby players (boys and girls, aged 13-18) licensed in RCT Association elite youth program (U14, U15, U16, U18). Integrated in specialized schools of Toulon metropolitan area with adapted schedules for dual academic-sport pathway. Medically followed by the Sports Medicine and Traumatology Unit (UMTS) at Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer (CHITS). All injuries recorded in Askamon database.

Description

Inclusion Criteria:

  • Licensed players (boys or girls) in the RCT Association program from U14 category onwards
  • Players presenting at least one injury requiring medical consultation between 01/08/2024 and 30/06/2026

Exclusion Criteria:

  • Opposition from participant or parents to participate in the research
  • Players not under medical responsibility of the RCT Association

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
French elite youth rugby players of Rugby Club Toulonnais
Youth rugby players (boys and girls, aged 13-18) licensed in RCT Association elite youth program (U14, U15, U16, U18) who present at least one injury during the two-season study period. Medically followed by the Sports Medicine and Traumatology Unit (UMTS).
Injury-related medical consultations provided by the Sports Medicine and Traumatology Unit (UMTS) at Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer (CHITS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury incidence rate among youth rugby players over two consecutive seasons
Time Frame: Up to 24 months
Number of injuries requiring a medical consultation divided by the total number of player-hours of exposure (training and matches), expressed as injuries per 1000 player-hours.
Up to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of injuries by type and anatomical location.
Time Frame: Up to 24 months
Proportion of injuries categorized by pathological category (e.g. sprain, fracture, contusion, concussion) and by anatomical region (e.g. upper limb, lower limb, head/neck, trunk).
Up to 24 months
Context of injury occurrence (match versus training, playing position and competition category).
Time Frame: Up to 24 months
Proportion of injuries occurring in matches versus training sessions, and distribution of injuries according to playing position (forwards or backs) and player category (U14, U15, U16, U18).
Up to 24 months
Frequency of recurrent injuries.
Time Frame: Up to 24 months
Number and proportion of players sustaining more than one injury during the two-season study period, and number of recurrent injuries per player.
Up to 24 months
Injury severity according to time-loss days.
Time Frame: Up to 24 months
Distribution of injuries by severity grade: Grade 0 (no time loss), Grade 1 (1-3 days), Grade 2 (4-7 days), Grade 3 (8-28 days), Grade 4 (>28 days).
Up to 24 months
Injury mechanisms.
Time Frame: Up to 24 months
Distribution of injuries by mechanism (running, tackling, ruck)
Up to 24 months
Environmental factors.
Time Frame: Up to 24 months
Distribution of injuries by environmental factors (playing surface, weather conditions, equipment status, and fatigue state).
Up to 24 months
Level of care.
Time Frame: Up to 24 months
Injury management will be detailed by level of care (on-field and off-field).
Up to 24 months
Medical specialist referrals.
Time Frame: Up to 24 months
Injury management will be detailed by medical specialist referrals.
Up to 24 months
Use of diagnostic facilities.
Time Frame: Up to 24 months
Injury management will be detailed by use of diagnostic facilities.
Up to 24 months
Medical procedures.
Time Frame: Up to 24 months
Injury management will be detailed by treatment or surgical procedures.
Up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tristan CANESSA, Strength/conditioning coach, RCT Association
  • Principal Investigator: Jean-Jacques RAYMOND, MD, CHITS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

January 5, 2026

First Submitted That Met QC Criteria

January 14, 2026

First Posted (Actual)

January 21, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025-CHITS-016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rugby-related Injuries

Clinical Trials on Medical consultation

Subscribe